IGF1 and cardiovascular disorder: Like low IGF-1 levels, ApoE ε4 was previously associated with an increased risk of developing cardiovascular disease and neurodegenerative disease (Corder et al., 1993; Eichner et al., 1993; Christensen et al., 2006).